Free fatty acids and protein kinase C activation induce GPR120 (free fatty acid receptor 4) phosphorylation. 2014

Omar B Sánchez-Reyes, and M Teresa Romero-Ávila, and Jean A Castillo-Badillo, and Yoshinori Takei, and Akira Hirasawa, and Gozoh Tsujimoto, and Rafael Villalobos-Molina, and J Adolfo García-Sáinz
Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ap. Postal 70-248, México D. F. 04510, Mexico.

GPR120, free fatty acid receptor 4, is a recently deorphanized G protein-coupled receptor that seems to play cardinal roles in the regulation of metabolism and in the pathophysiology of inflammatory and metabolic disorders. In the present work a GPR120-Venus fusion protein was expressed in HEK293 Flp-In T-REx cells and its function (increase in intracellular calcium) and phosphorylation were studied. It was observed that the fusion protein migrated in sodium dodecyl sulfate-polyacrylamide gels as a band with a mass of ≈70-75kDa, although other bands of higher apparent weight (>130kDa) were also detected. Cell stimulation with docosahexaenoic acid or α-linolenic acid induced concentration-dependent increases in intracellular calcium and GPR120 phosphorylation. Activation of protein kinase C with phorbol esters also induced a marked receptor phosphorylation but did not alter the ability of 1µM docosahexaenoic acid to increase the intracellular calcium concentration. Phorbol ester-induced GPR120 phosphorylation, but not that induced with docosahexaenoic acid, was blocked by protein kinase C inhibitors (bis-indolyl-maleimide I and Gö 6976) suggesting that conventional kinase isoforms mediate this action. The absence of effect of protein kinase C inhibitors on agonist-induced GPR120 phosphorylation indicates that this kinase does not play a major role in agonist-induced receptor phosphorylation. Docosahexaenoic acid action was associated with marked GPR120 internalization whereas that induced with phorbol esters was smaller at early times.

UI MeSH Term Description Entries
D010703 Phorbol Esters Tumor-promoting compounds obtained from CROTON OIL (Croton tiglium). Some of these are used in cell biological experiments as activators of protein kinase C. Phorbol Diester,Phorbol Ester,Phorbol Diesters,Diester, Phorbol,Diesters, Phorbol,Ester, Phorbol,Esters, Phorbol
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D004281 Docosahexaenoic Acids C22-unsaturated fatty acids found predominantly in FISH OILS. Docosahexaenoate,Docosahexaenoic Acid,Docosahexenoic Acids,Docosahexaenoic Acid (All-Z Isomer),Docosahexaenoic Acid Dimer (All-Z Isomer),Docosahexaenoic Acid, 3,6,9,12,15,18-Isomer,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer),Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cerium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Cesium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(All-Z-Isomer), Potassium Salt,Docosahexaenoic Acid, 4,7,10,13,16,19-(Z,Z,Z,Z,Z,E-Isomer),Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer,Docosahexaenoic Acid, 4,7,10,13,16,19-Isomer, Sodium Salt,Docosahexaenoic Acid, Sodium Salt,Acid, Docosahexaenoic,Acids, Docosahexaenoic,Acids, Docosahexenoic
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013755 Tetradecanoylphorbol Acetate A phorbol ester found in CROTON OIL with very effective tumor promoting activity. It stimulates the synthesis of both DNA and RNA. Phorbol Myristate Acetate,12-Myristoyl-13-acetylphorbol,12-O-Tetradecanoyl Phorbol 13-Acetate,Tetradecanoylphorbol Acetate, 4a alpha-Isomer,12 Myristoyl 13 acetylphorbol,12 O Tetradecanoyl Phorbol 13 Acetate,13-Acetate, 12-O-Tetradecanoyl Phorbol,Acetate, Phorbol Myristate,Acetate, Tetradecanoylphorbol,Myristate Acetate, Phorbol,Phorbol 13-Acetate, 12-O-Tetradecanoyl,Tetradecanoylphorbol Acetate, 4a alpha Isomer
D043562 Receptors, G-Protein-Coupled The largest family of cell surface receptors involved in SIGNAL TRANSDUCTION. They share a common structure and signal through HETEROTRIMERIC G-PROTEINS. G Protein Coupled Receptor,G-Protein-Coupled Receptor,G-Protein-Coupled Receptors,G Protein Coupled Receptors,Receptor, G-Protein-Coupled,Receptors, G Protein Coupled
D057809 HEK293 Cells A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5. 293T Cells,HEK 293 Cell Line,HEK 293 Cells,Human Embryonic Kidney Cell Line 293,Human Kidney Cell Line 293,293 Cell, HEK,293 Cells, HEK,293T Cell,Cell, 293T,Cell, HEK 293,Cell, HEK293,Cells, 293T,Cells, HEK 293,Cells, HEK293,HEK 293 Cell,HEK293 Cell

Related Publications

Omar B Sánchez-Reyes, and M Teresa Romero-Ávila, and Jean A Castillo-Badillo, and Yoshinori Takei, and Akira Hirasawa, and Gozoh Tsujimoto, and Rafael Villalobos-Molina, and J Adolfo García-Sáinz
June 2008, Naunyn-Schmiedeberg's archives of pharmacology,
Omar B Sánchez-Reyes, and M Teresa Romero-Ávila, and Jean A Castillo-Badillo, and Yoshinori Takei, and Akira Hirasawa, and Gozoh Tsujimoto, and Rafael Villalobos-Molina, and J Adolfo García-Sáinz
July 2019, European journal of pharmacology,
Omar B Sánchez-Reyes, and M Teresa Romero-Ávila, and Jean A Castillo-Badillo, and Yoshinori Takei, and Akira Hirasawa, and Gozoh Tsujimoto, and Rafael Villalobos-Molina, and J Adolfo García-Sáinz
November 1991, FEBS letters,
Omar B Sánchez-Reyes, and M Teresa Romero-Ávila, and Jean A Castillo-Badillo, and Yoshinori Takei, and Akira Hirasawa, and Gozoh Tsujimoto, and Rafael Villalobos-Molina, and J Adolfo García-Sáinz
January 2017, Handbook of experimental pharmacology,
Omar B Sánchez-Reyes, and M Teresa Romero-Ávila, and Jean A Castillo-Badillo, and Yoshinori Takei, and Akira Hirasawa, and Gozoh Tsujimoto, and Rafael Villalobos-Molina, and J Adolfo García-Sáinz
January 2021, Biomolecules & therapeutics,
Omar B Sánchez-Reyes, and M Teresa Romero-Ávila, and Jean A Castillo-Badillo, and Yoshinori Takei, and Akira Hirasawa, and Gozoh Tsujimoto, and Rafael Villalobos-Molina, and J Adolfo García-Sáinz
April 2009, Naunyn-Schmiedeberg's archives of pharmacology,
Omar B Sánchez-Reyes, and M Teresa Romero-Ávila, and Jean A Castillo-Badillo, and Yoshinori Takei, and Akira Hirasawa, and Gozoh Tsujimoto, and Rafael Villalobos-Molina, and J Adolfo García-Sáinz
July 2014, Bioorganic & medicinal chemistry letters,
Omar B Sánchez-Reyes, and M Teresa Romero-Ávila, and Jean A Castillo-Badillo, and Yoshinori Takei, and Akira Hirasawa, and Gozoh Tsujimoto, and Rafael Villalobos-Molina, and J Adolfo García-Sáinz
July 2014, The Journal of biological chemistry,
Omar B Sánchez-Reyes, and M Teresa Romero-Ávila, and Jean A Castillo-Badillo, and Yoshinori Takei, and Akira Hirasawa, and Gozoh Tsujimoto, and Rafael Villalobos-Molina, and J Adolfo García-Sáinz
January 1994, Journal of pharmaceutical science and technology : the official journal of PDA,
Omar B Sánchez-Reyes, and M Teresa Romero-Ávila, and Jean A Castillo-Badillo, and Yoshinori Takei, and Akira Hirasawa, and Gozoh Tsujimoto, and Rafael Villalobos-Molina, and J Adolfo García-Sáinz
June 2016, Biochemical pharmacology,
Copied contents to your clipboard!